[Is interleukin 2 useful in oncology?].
Négrier
S
S
Département de cancérologie médicale Centre Léon-Bérard, Lyon.
D003131:Combined Modality Therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000556:secondary* / Q000628:therapy*; D008545:Melanoma / Q000556:secondary* / Q000628:therapy*; D018579:Patient Selection; D012878:Skin Neoplasms / Q000556:secondary* / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D007376:Interleukin-2; D007372:Interferons
L'interleukine 2 est-elle utile en cancérologie?